Key result
Concomitant initiation of antihypertensive and lipid-lowering therapy, along with reducing pill burden, can significantly improve adherence in patients.
Why the study?
Does concomitant initiation and reduced pill burden improve adherence in patients prescribed antihypertensive and lipid-lowering therapy?
Population
Patients prescribed concomitant antihypertensive (AH) and lipid-lowering (LL) therapy
Follow-up
6 months
Authors
Loading...
May boost adherence via simultaneous initiation and fewer pills; leaves open need for randomized confirmation.
Does concomitant initiation and reduced pill burden improve adherence in patients prescribed antihypertensive and lipid-lowering therapy?
Adherence to concomitant antihypertensive and lipid-lowering therapy is poor but may be improved by concomitant initiation and reducing pill burden.
Richard H. Chapman (2005) studied this question. Concomitant initiation of antihypertensive and lipid-lowering therapy, along with reducing pill burden, can significantly improve adherence in patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: